Introduction
Although there is a variety of 
FOLLOW-UP
Follow-up examinations were performed on patients in all three groups 3-7 days after the end of treatment; for patients who were mycologically cured at this time a second follow-up examination was carried out one month after the end of treatment to determine rates of recurrence of candidosis.
On admission to the study and at subsequent follow-up examinations the patients were assessed clinically for severity of the following signs and symptoms; vaginal discharge, vulval pruritus, dysuria, dyspareunia, and vulval erythema. These features were rated as: "absent," "mild," or "more or less severe." A vaginal swab was also taken at each examination for culture of Candida species.
STATISTICS
Statistical evaluation of the differences in mycological cure rates between groups A, B, and C was performed using the x2 test (2 x 2 contingency table, two-tailed) with Yates's correction.
Results

CURE RATES
About 93% of patients in groups A and B had become culture-negative for Candida 3-7 days after treatment with miconazole-coated tampons (table  II) ; however the mycological cure rate for patients in group C was only 61%o. The differences in mycological cure rates between groups A and C (x2= 22X216, P<0-0001) and between groups B and C (' 2 1669886, P<0 0001) were statistically significant. In all three groups patients who became Candida-negative remained so; mycological recurrence rates were less than 4% for all three groups (table II) .
RELIEF OF SYMPTOMS
The high mycological cure rates in groups A and B were reflected by high rates of relief from symptoms of candidosis (table III) . On admission almost all the patients in these groups had "more or less" severe discharge and pruritus, but the frequency of these symptoms was reduced to less than 9% 3-7 days after treatment, with only low rates of recurrence or persistence of symptoms among mycologically cured patients assessed one month after treatment. Among patients in group C the reduction in frequency of vaginal discharge was less impressive than for groups A and B, although the relief of pruritus was similar to that for groups A and B. The other symptoms and signs of vaginal candidosis were noted less often than pruritus and discharge at the time of admission to the study; they were relieved successfully for all but a few patients with all three treatment regimens.
SUBJECTIVE ASSESSMENT
The miconazole-coated tampons were well accepted by all the patients. More than 80%o of patients in group A and 69% of patients in group B subjectively described the results of their treatment as excellent, Comparison of the data for groups B and C of the present study however suggests that it may be the total dose rather than the time during which the dose is given which is the important factor.
Future studies should be designed to investigate the relationship between the total antifungal dose, duration of therapy, and therapeutic success in order to establish optimal conditions for the topical treatment of vaginal candidosis. 
